Cubist Systematic Strategies, LLC Pharvaris N.V. Transaction History
Cubist Systematic Strategies, LLC
- $15.6 Billion
- Q1 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 2,278 shares of PHVS stock, worth $40,981. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,278
Previous 3,336
31.71%
Holding current value
$40,981
Previous $63,000
44.44%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PHVS
# of Institutions
50Shares Held
39.1MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$135 Million3.99% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.41MShares$79.3 Million78.82% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$77.2 Million72.08% of portfolio
-
Viking Global Investors LP3.65MShares$65.7 Million0.19% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$59.4 Million17.41% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $607M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...